#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Epstein-Barr virus associated lymphoproliferative disorder Hyperadrenocorticism Amyotrophic lateral sclerosis Thymic carcinoma Drug eruption Haematological malignancy Primary myelofibrosis Liver transplant rejection Non-small cell lung cancer Methylmalonic acidaemia Ventricular tachycardia Rett syndrome Oesophageal adenocarcinoma stage II Pulmonary tuberculosis X-linked lymphoproliferative syndrome More trials…

    Learn about Rare Diseases

    Ewing’s sarcoma metastatic – Treatment Ewing’s sarcoma metastatic – Trials in Disease Splenic marginal zone lymphoma – Trials in Disease Hepatoblastoma – Life with Disease Angiosarcoma non-metastatic – Basic Information Medulloblastoma recurrent – Basic Information Marfan’s syndrome – Treatment Atypical haemolytic uraemic syndrome – Trials in Disease Osteosarcoma metastatic – Treatment Pulmonary fibrosis More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    GSKVX000000034792 CAMOSTAT MESILATE Zasocitinib FRUQUINTINIB BRENSOCATIB Olopatadine Balcinrenone Tadekinig Alfa Esketamine Hydrochloride Cytisinicline Lutetium (177Lu) Oxodotreotide S227928 Human Serum Albumin 5% Bromhexine Hydrochloride At-1501 Abc-31-116 Alks 2680 Fluoroethyltyrosine F-18 ZIMISLECEL Abc-15Bo-116 More therapies…

    Learn about Your Condition

    Immunosuppression Noninfective chorioretinitis Prodromal Alzheimer's disease Meningioma malignant Cataract Skin bacterial infection Diabetic ketoacidosis Dupuytren's contracture Medication overuse headache Vulvovaginal discomfort Tourette's disorder Poor quality sleep B-cell lymphoma refractory Cerebral haemorrhage Hypoglycaemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Azienda Ospedaliera di Padova

Azienda Ospedaliera di Padova

Via Nicolo' Giustiniani 2, Padua, 35128, Italy

Want to learn more about this study or check if you can participate? Contact us.

  • A study to evaluate the efficacy and safety of vixarelimab in patients with moderate to severe ulcerative colitis

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Mercaptopurine
    • Methotrexate Sodium
    • Vixarelimab
    Belgium Czechia France Germany Greece Italy +1

  • A study to evaluate the long-term safety and effectiveness of balinatunfib in adults with Crohn’s disease or ulcerative colitis

    Not recruiting

    2 1
    Investigated Diseases:
    • Colitis ulcerative
    • Crohn’s disease
    Austria Belgium Bulgaria Croatia Czechia France +8

  • Efficacy and Safety Evaluation of Odevixibat in Pediatric Biliary Atresia Post-Kasai Hepatoportoenterostomy: A Double-Blind, Randomized, Placebo-Controlled Trial

    Not recruiting

    3 1
    Investigated Drugs:
    • Odevixibat
    Belgium France Germany Hungary Italy The Netherlands +2

  • Efficacy and Safety Evaluation of Litifilimab in Adults with Active Systemic Lupus Erythematosus on Standard Nonbiologic Lupus Care: A Phase 3 Randomized Controlled Trial

    Not recruiting

    3 1
    Investigated Diseases:
    • Systemic lupus erythematosus
    Investigated Drugs:
    • Litifilimab
    Belgium Czechia Germany Hungary Italy The Netherlands +1

  • Efficacy and Safety of Maintenance Cabozantinib Plus Best Supportive Care in Pediatric and AYA Patients with Unresectable Residual Osteosarcoma

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Osteosarcoma
    Investigated Drugs:
    • Cabozantinib
    Austria Belgium Denmark France Germany Ireland +5

  • A study testing NNC0194-0499, cagrilintide, and semaglutide alone or combined to treat liver damage in people with alcohol-related liver disease

    Not recruiting

    2 1
    Investigated Diseases:
    • Alcoholic liver disease
    Investigated Drugs:
    • ZALFERMIN
    • Cagrilintide
    • Semaglutide
    Bulgaria Czechia Denmark France Germany Greece +4

  • Study of IPX203 compared to levodopa/carbidopa in patients with advanced Parkinson’s disease and motor fluctuations

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Benserazide Hydrochloride
    • Levodopa
    Italy Poland Spain

  • Study of Navenibart to prevent attacks in adults and adolescents with Hereditary Angioedema

    Not recruiting

    3 1
    Investigated Diseases:
    • Hereditary angioedema
    • Hereditary angioedema with C1 esterase inhibitor deficiency
    Investigated Drugs:
    • NAVENIBART
    Austria Bulgaria Czechia France Germany Hungary +5

  • Study of radiotherapy with durvalumab and ceralasertib in patients with stage III non-small cell lung cancer who have thoracic relapse after PACIFIC treatment

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer stage III
    Investigated Drugs:
    • Ceralasertib
    • Durvalumab
    Italy

  • Study of BLU-808 tablets compared to placebo in adults with chronic inducible urticaria and chronic spontaneous urticaria

    Not recruiting

    2 1
    Denmark Germany Italy Spain
Previous Page
1 … 21 22 23 24 25 … 41
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!